1-(3-(2-methoxyethyl)-1,2,4-oxadiazol-5-yl)-3-(methylthio)propan-1-amine oxalate, 95.0%, 250mg

6-chloro-3-(3-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 250mg

cis-3-Hexenyl Hexanoate, 98.0%, 100g

tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate, 95.0%, 5g

3-Ethyl-2-methylbenzothiazolium Iodide>98.0%(HPLC)(T)25g

(+/-)-1-(Trifluoromethyl)cyclopentanamine hydrochloride, 97.0%, 1g

Platinum(IV) oxide, 95.0%, 1g

2-Amino-5-iodo-pyrimidine, 97.0%, 100g

Benzaldehyde, min. 99.5%, for synthesis, 500 ml, glass packaging

O-(2-Fluorobenzyl)hydroxylamine, 95+%, 5g

(R)-3-(6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one, 98%, 50mg

Ethyl 2-formylisonicotinate, 95.0%, 100mg

3-Pyrazin-2-ylbenzoic acid, 97.0%, 250mg